2020-12-18 updated
CYBERDYNE Inc. [Tsukuba, Ibaraki, CEO: Yoshiyuki Sankai (the “Company”)] obtained medical device approval from Singapore Health Science Authority for its product, Medical HAL. Similar to the approvals obtained in the US and EU, the approval for Singapore covers wide types of diseases such as stroke, spinal cord injury, and Neuromuscular Diseases.
The Company is working to promote Medical HAL in Japan, the US, the EU, and the APAC. This approval in Singapore followed the successful approvals in Malaysia, Thailand, Indonesia, Australia, and Taiwan.
© 2024 CYBERDYNE INC. ALL RIGHTS RESERVED.